Hege Sagstuen Haugnes
Job description
Jeg jobber som professor i onkologi i 50% stilling ved UiT, kombinert med 50% stilling som seksjonsoverlege i uro-onkologi ved Universitetssykehuset Nord-Norge
Anna K. Jansson,
Gabriella Cohn-Cedermark,
Helene Francisca Stigter Negaard,
Torgrim Tandstad,
Olof Ståhl,
Annika Hedlund
et al.:
High-dose chemotherapy in male germ cell cancer patients—a study by the SWENOTECA group
Hege Sagstuen Haugnes,
Håkon Kjæve,
Eivind Bjerkaas,
Ragnhild Hellesnes,
Line Veronika Hjelle,
Magnus Larsen
:
Real-world data on utilization of neoadjuvant chemotherapy for muscle invasive bladder cancer: impact on surgical complications and oncological efficacy
Selina R. van den Oever,
Renée L. Mulder,
Kevin C. Oeffinger,
Jourik A. Gietema,
Roderick Skinner,
Louis S. Constine
et al.:
Metabolic syndrome in childhood, adolescent, and young adult cancer survivors: recommendations for surveillance from the International Late Effects of Childhood Cancer Guideline Harmonization Group
Sophie Dorothea Fosså,
Lars Johan Bjerner,
Torgrim Tandstad,
Marianne Brydøy,
Alv A Dahl,
Ragnhild Veline Nome
et al.:
Biochemical Hypogonadism in Aging Testicular Cancer Survivors: A Clinical Challenge
Anna Thor,
Mette Pernille Myklebust,
Anna Grenabo Bergdahl,
Per-Olof Lundgren,
Viktor Skokic,
Bjarte Almås
et al.:
miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR Study
Martin Støyten,
Tore Knutsen,
Einar Stikbakke,
Ingvild Agledahl,
Tom Wilsgaard,
Anne Elise Eggen
et al.:
Excess weight, weight gain, and prostate cancer risk and prognosis: the PROCA-life study
Rune Sundset,
Hege Sagstuen Haugnes,
Alexander Perez,
Ola Engelsen,
Ida Fosseide,
Miguel Castillejo
et al.:
Behandling av kastrasjonsresistent metastatisk prostatakreft med [177Lu]PSMA-radioligand
Axel Gerdtsson,
Helene Francisca Stigter Negaard,
Bjarte Almås,
Anna Grenabo Bergdahl,
Gabriella Cohn-Cedermark,
Ingrid Glimelius
et al.:
Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours
Anna Thor,
Helene Francisca Stigter Negaard,
Anna Grenabo Bergdahl,
Bjarte Almås,
Signe Melsen Larsen,
Per-Olof Lundgren
et al.:
Primary Retroperitoneal Lymph Node Dissection as Treatment for Low-volume Metastatic Seminoma in a Population-based Cohort: The Swedish Norwegian Testicular Cancer Group Experience
Sophie Dorothea Fosså,
Hege Sagstuen Haugnes,
Alv A Dahl,
Cecilie E. Kiserud,
Alexander Fosså,
Jakob Rasmussen Skalleberg
et al.:
Adverse health outcomes and global quality of life in long-term testicular cancer survivors: a longitudinal 30-year perspective
Axel Gerdtsson,
Gustav Torisson,
Anna Thor,
Anna Grenabo Bergdahl,
Bjarte Almås,
Ulf Håkansson
et al.:
Validation of a prediction model for post-chemotherapy fibrosis in nonseminoma patients
Marie Grøn Sælen,
Line Veronika Hjelle,
Erling Johan Aarsæther,
Tore Knutsen,
Sigve Andersen,
Anne Gry Bentzen
et al.:
Patient-reported outcomes after curative treatment for prostate cancer with prostatectomy, primary radiotherapy or salvage radiotherapy
Ramesh Upreti,
Elia Mmbaga,
Hege Sagstuen Haugnes,
Cecilie E. Kiserud,
Ruby del Risco Kollerud
:
Most common health problems in general practice among adolescents, and young adults’ survivors of lymphoma: a register-based cohort study in Norway
Line Veronika Hjelle,
Marie Grøn Sælen,
Erling Johan Aarsæther,
Tore Knutsen,
Sigve Andersen,
Anne Gry Bentzen
et al.:
The Longitudinal Course of Prospectively Recorded Patient-reported Outcomes in Prostate Cancer Patients Treated with Surgery and Salvage Radiotherapy
Lene Thorsen,
Kerry S. Courneya,
Jostein Steene-Johannessen,
Jon Michael Gran,
Hege Sagstuen Haugnes,
Helene Francisca Stigter Negaard
et al.:
Association of physical activity with overall mortality among long-term testicular cancer survivors: A longitudinal study
Einar Stikbakke,
Tom Wilsgaard,
Hege Sagstuen Haugnes,
Mona Irene Pedersen,
Tore Knutsen,
Martin Støyten
et al.:
Expression of miR-24-1-5p in Tumor Tissue Influences Prostate Cancer Recurrence: The PROCA-life Study
Jan Oldenburg,
D.M. Berney,
C. Bokemeyer,
Miguel Angel Climent,
G. Daugaard,
Jourik A. Gietema
et al.:
Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
Sophie Dorothea Fosså,
Alv A Dahl,
Lene Thorsen,
Ragnhild Hellesnes,
Cecilie E. Kiserud,
Torgrim Tandstad
et al.:
Mortality and Second Cancer Incidence after Treatment for Testicular Cancer: Psychosocial Health and Lifestyle Are Modifiable Prognostic Factors
Mette Pernille Myklebust,
Anna Thor,
Nina Benedikte Rosenlund,
Peder Gjengstø,
Åsa Karlsdottir,
Marianne Brydøy
et al.:
Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study
Axel Gerdtsson,
Anna Thor,
Anna Bergdahl Grenabo,
Bjarte Almås,
Ulf Håkansson,
Magnus Törnblom
et al.:
Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group
Anders W. Bjerring,
Sophie Dorothea Fosså,
Hege Sagstuen Haugnes,
Ragnhild Veline Nome,
Thomas Muri Stokke,
Kristina Haugaa
et al.:
The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: A 30-year follow-up
Ragnhild Hellesnes,
Tor Åge Myklebust,
Roy M. Bremnes,
Åsa Karlsdottir,
Øivind Kvammen,
Helene Francisca Stigter Negaard
et al.:
Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study
Hege S. Haugnes,
Helene Francisca Stigter Negaard,
Hilde Jensvoll,
Tom Wilsgaard,
Torgrim Tandstad,
Arne Solberg
:
Thromboembolic Events During Treatment with Cisplatin-based Chemotherapy in Metastatic Testicular Germ-cell Cancer 2000–2014: A Population-based Cohort Study
Einar Stikbakke,
Henrik Schirmer,
Tore Knutsen,
Martin Støyten,
Tom Wilsgaard,
Edward L. Giovannucci
et al.:
Systolic and diastolic blood pressure, prostate cancer risk, treatment, and survival. The PROCA-life study
Ragnhild Hellesnes,
Tor Åge Myklebust,
Sophie Dorothea Fosså,
Roy M. Bremnes,
Åsa Karlsdottir,
Øivind Kvammen
et al.:
Testicular cancer in the cisplatin era: Causes of death and mortality rates in a population-based cohort
Synne-Kristin Hoffart Bøhn,
Hanne Cathrine Lie,
Kristin Valborg Reinertsen,
Sophie Dorothea Fosså,
Hege Sagstuen Haugnes,
Cecilie E. Kiserud
et al.:
Lifestyle among long-term survivors of cancers in young adulthood
Hanne Skjerven Bersvendsen,
Hege Sagstuen Haugnes,
Alv A Dahl,
Unn-Merete Fagerli,
Øystein Fluge,
Harald Holte
et al.:
Sexual dysfunction is prevalent in female lymphoma survivors after autologous stem-cell transplantation and is associated with younger age, chronic fatigue, and mental distress
Axel Gerdtsson,
Ulf Håkansson,
Magnus Törnblom,
George Jancke,
Helene Francisca Stigter Negaard,
Ingrid Glimelius
et al.:
Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group
Lene Thorsen,
Hege Sagstuen Haugnes,
Sophie Dorothea Fosså,
Marianne Brydøy,
Torgrim Tandstad,
Torbjørn Wisløff
et al.:
Thromboembolic events after high-intensity training duringcisplatin-based chemotherapy for testicular cancer: Casereports and review of the literature
Ruby Del Risco Kollerud,
Hege Sagstuen Haugnes,
Bjørgulf Claussen,
Magne Thoresen,
Per Nafstad,
James Farnham
et al.:
A population-based study of testicular cancer risk among children and young adults from Norway and Utah, USA.
Sophie Dorothea Fosså,
Alv A Dahl,
Tor Åge Myklebust,
Cecilie E. Kiserud,
Ragnhild Veline Nome,
Olbjørn Klepp
et al.:
Risk of positive selection bias in longitudinal surveys among cancer survivors: Lessons learnt from the national Norwegian Testicular Cancer Survivor Study
Ruby Del Risco Kollerud,
LA Cannon-Albright,
Hege Sagstuen Haugnes,
Ellen Ruud,
Magne Thoresen,
Per Nafstad
et al.:
Childhood central nervous system tumors and leukemia: Incidence and familial risk. A comparative population-based study in Utah and Norway.
Synne-Kristin Hoffart Bøhn,
Lene Thorsen,
Cecilie E. Kiserud,
Sophie Dorothea Fosså,
Hanne Cathrine Lie,
Jon Håvard Loge
et al.:
Chronic fatigue and associated factors among long-term survivors of cancers in young adulthood
Hanne Skjerven Bersvendsen,
Hege Sagstuen Haugnes,
Unn-Merete Fagerli,
Øystein Fluge,
Harald Holte,
Knut Bjøro Smeland
et al.:
Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes
Hanne Skjerven Bersvendsen,
Hege Sagstuen Haugnes,
Alv A Dahl,
Unn-Merete Fagerli,
Øystein Fluge,
Harald Holte
et al.:
Sexual function in long-term male lymphoma survivors after high-dose therapy with autologous stem-cell transplantation
Einar Stikbakke,
Elin Richardsen,
Tore Knutsen,
Tom Wilsgaard,
Edward L. Giovannucci,
Anne McTiernan
et al.:
Inflammatory serum markers and risk and severity of prostate cancer: The PROCA‐life study
Cecilie Bucher-Johannessen,
Christian Magnus Page,
Trine B. Haugen,
Marcin Wojewodzic,
Sophie Dorothea Fosså,
Tom Grotmol
et al.:
Cisplatin treatment of testicular cancer patients introduces long-term changes in the epigenome
Yahia Al-Jebari,
Ingrid Glimelius,
Carina Berglund Nord,
Gabriella Cohn-Cedermark,
Olof Ståhl,
Torgrim Tandstad
et al.:
Cancer therapy and risk of congenital malformations in children fathered by men treated for testicular germ-cell cancer: A nationwide register study
Ruby Del Risco Kollerud,
Ellen Ruud,
Hege Sagstuen Haugnes,
Lisa A. Cannon-Albright,
Magne Thoresen,
Per Nafstad
et al.:
Family history of cancer and risk of paediatric and young adult’s testicular cancer: A Norwegian cohort study
Ragnhild Hellesnes,
Øivind Kvammen,
Tor Åge Myklebust,
Roy M. Bremnes,
Åsa Karlsdottir,
Helene Francisca Stigter Negaard
et al.:
Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era
F Honecker,
J Aparicio,
D Berney,
J Beyer,
C Bokemeyer,
R Cathomas
et al.:
ESMO consensus conference on testicular germ cell cancer: Diagnosis, treatment and follow-up
Line Veronika Hjelle,
Per Ole Mobråten Gundersen,
Ragnhild Hellesnes,
Mette Sprauten,
Marianne Brydøy,
Torgrim Tanstad
et al.:
Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors
Sven Löffeler,
Helena Maria Bertilsson,
Christoph Rainer Müller,
Kirsti Aas,
Hege Sagstuen Haugnes,
Bjørg Yksnøy Aksnessæther
et al.:
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P)
Torgrim Tandstad,
Ragnhild Hellesnes,
Åsa Karlsdottir,
Øivind Kvammen,
Carl W. Langberg,
Helene Francisca Stigter Negaard
et al.:
Late relapse in testicular cancer: A report from a national cohort. Oral presentation
2022 ARKIV
Ingerid Skjei Knudtsen,
Bendik Skarre Abrahamsen,
Kirsten Margrete Selnæs,
Mattijs Elschot,
Sverre Langørgen,
Thomas Keil
et al.:
PSMA-PET-avbildning før primærbehandling av pasienter med høyrisiko prostatakreft
2022 ARKIV
Torgrim Tandstad,
Ragnhild Hellesnes,
Hege Sagstuen Haugnes,
Åsa Karlsdottir,
Carl W. Langberg,
Helene Francisca Stigter Negaard
et al.:
Late relapses in testicular cancer: Results from a national cohort
Hege Sagstuen Haugnes
:
Presentasjon av kreft seneffekt poliklinikken ved UNN
2022 ARKIV
Hege Sagstuen Haugnes
:
Presentasjon av seneffekt poliklinikken ved UNN
2022 ARKIV
B. Jordan,
A. Margulies,
F. Cardoso,
G. Cavaletti,
Hege Sagstuen Haugnes,
P. Jahn
et al.:
Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up
Einar Stikbakke,
Hege Sagstuen Haugnes,
Inger Thune,
Tom Wilsgaard,
Anne Elise Eggen,
Tore Knutsen
et al.:
Pre-diagnostic Inflammation Score and risk of Prostate Cancer. The PROCA-life study
2018 ARKIV
The 50 latest publications is shown on this page. See all publications in Cristin here →
Research interests
Jeg er opptatt av forskning med fokus på 1) seneffekter etter kreftbehandling, 2) diagnostikk, behandling og oppfølging innen urologisk kreft (med fokus på testikkelkreft og prostatakreft) og 3) kliniske kreftforskningsprosjekter knyttet til Tromsøundersøkelsen (prostatakreft og brystkreft).
Teaching
Jeg har mange års erfaring med å undervise i onkologi ved medisinstudiet, og er hovedansvarlig for delemne 6.4F ved campus Hammerfest.